BioSpace News Archive

DisperSol Technologies, LLC, a specialty pharmaceutical company, today announced the appointment of Tim Scott as president and chief executive officer (CEO) of the company.

The growth of the gastrointestinal diagnostics market is attributed to the increasing incidence of gastrointestinal disorders such as gastric infections, IBD, GERD, GI bleeding, and others.

According to Vision Research Reports, the global immunotherapy drugs market was estimated at USD 110.74 billion in 2021 and it is expected to surpass around USD 200.62 billion by 2030, poised to grow at a CAGR of 6.83% from 2022 to 2030

The global preclinical medical device testing services market was valued at USD 2.5 billion in 2021 and it is predicted to surpass around USD 5.18 billion by 2030 with a CAGR of 8.43% from 2022 to 2030

Pharmaceutical industry is progressing at a rapid rate to cover the various diseases that affect human beings.

Homecare oxygen concentrators are usually used in providing supplemental oxygen to wide range of patients with respiratory problems.

Brain cells with the same “birthdate” are more likely to wire together into cooperative signaling circuits that carry out many functions, including the storage of memories, a new study finds.

FIGUR8, the digital health company that’s developed the most advanced musculoskeletal (MSK) health evaluation solution on the market, announced today that the American Medical Association (AMA) has issued a new technology-specific Category III Current Procedural Terminology (CPT®) code for FIGUR8’s musculoskeletal technology.

The National Institute of Allergy and Infectious Disease (NIAID) awarded a $6.9 million grant to researchers at the Institute for Bioscience and Biotechnology Research (IBBR) to design a vaccine to combat the virus that causes Hepatitis C, an illness that affects an estimated 71 million people worldwide.

Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.